Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol versus fentanyl as adjuvants to bupivacaine for axillary brachial plexus block
PACTR202001635673534Phase 4Completed
- Sponsor
- Dilla University
- Start
- Oct 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pain comparing Bupivacaine alone, Bupivacaine plus tramadol and Bupivacaine plus fentanyl (3 arms). Primary endpoints: Time to onset of complete sensory block, Time to onset of complete motor block and 5 more. Started Oct 2018; status: completed.
02
Drugs
bupivacainetramadolfentanyl
03
Conditions
pain
Beyond the preview
Go deeper on PACTR202001635673534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202001635673534.